Key Dates

Related Announcements

NOT-OD-23-006 - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: May 2023 Councils

NOT-OD-22-047 - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2022 Councils

NOT-OD-21-179 - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: May 2022 Council

NOT-OD-21-095 - RESCINDED - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: January 2022 Council

NOT-OD-20-179 - RESCINDED - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2021 Councils

NOT-OD-20-163 - RESCINDED - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic

NOT-OD-20-123 - RESCINDED - Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic

NOT-OD-19-083 - Update to the NIH/AHRQ/NIOSH Policy on Post-Submission Materials

Issued by

NATIONAL INSTITUTES OF HEALTH (NIH)

Purpose

This Notice extends the special exception for post-submission material (see NOT-OD-20-123; NOT-OD-20-163; NOT-OD-20-179; NOT-OD-21-095; NOT-OD-21-179; NOT-OD-22-047) to applications submitted for the January 2023 Council rounds.

For applications submitted for the January 2023 Council rounds (beginning with applications submitted for the May 25, 2022 due date), the NIH, AHRQ, and NIOSH will accept a one-page update with preliminary data as post-submission materials for applications submitted under all activity codes, ONLY if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application. One page of preliminary data will be accepted for single component applications or for each component of a multi-component application.

The deadline for submitting all post-submission materials, including preliminary data, will be 30 days before the study section meeting, unless specified otherwise in the FOA. Because applications for emergency competitive revisions and urgent competitive revisions undergo expedited review, post-submission materials will not be accepted for those applications.

All other materials listed in NOT-OD-19-083 as acceptable post-submission materials will continue to be accepted if submitted 30 days before the study section meeting. Instructions for submission are included in NOT-OD-19-083.

Inquiries

Please direct all inquiries to:

NIH Review Policy Officer
[email protected]

Francis D. Chesley, Jr., M.D.
Agency for Healthcare Research and Quality
Telephone: 301-427-1521
Email: [email protected]

Steve Dearwent, Ph.D.
Centers for Disease Control and Prevention
Telephone: 404-498-6382
Email: [email protected]

Michael Goldcamp, Ph.D.
Centers for Disease Control and Prevention
Telephone: 304-285-5951
Email: [email protected]